OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
8935$18.5058

Pontex Polyblend Co Ltd

Commodity ChemicalsVerified

Pontex Polyblend Co Ltd has a price-to-book ratio of 2.43 and a price-to-tangible-book ratio of 2.43, indicating a premium valuation relative to its book value. The company's market capitalization is 2,099,657,500 TWD, with a market price of 18.5 TWD per share. The enterprise value to EBITDA ratio is negative at -25.61, reflecting the company's current operating losses. The enterprise value to revenue ratio is 4.65, suggesting a moderate revenue-based valuation. The company's profitability is weak, with a return on equity of -0.1 and a return on assets of -0.0596, both significantly below the industry median for Commodity Chemicals. The operating margin is negative at -18.1%, and the net profit margin is also negative at -16.7%, indicating poor cost control and revenue generation relative to its peers. Pontex Polyblend Co Ltd operates through two business segments: Equipment Components and Composite Materials. The geographic exposure is primarily in Taiwan and the rest of Asia, with no specific revenue concentration disclosed. The company's revenue is not heavily concentrated in any single region or customer, but the lack of detailed segment revenue data limits the ability to assess concentration risk. The company's growth trajectory is uncertain, with no specific revenue growth projections provided. The operating cash flow is positive at 13,151,000 TWD, but the free cash flow is negative at -52,559,000 TWD, indicating that the company is not generating sufficient cash to fund its operations and capital expenditures. The capital expenditure for the period is -10,215,000 TWD, suggesting some investment in long-term assets. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company has a debt-to-equity ratio of 0.59 and a current ratio of 1.55, suggesting moderate leverage and adequate short-term liquidity. However, the key flag of negative net cash after subtracting total debt highlights a potential liquidity constraint. Recent events include the publication of the 2023 annual report, which provides the latest financial and operational data. No significant recent filings or transcripts have been disclosed that would indicate major changes in the company's strategic direction or financial health.

30-day price · 8935+0.50 (+2.6%)
Low$17.60High$20.95Close$19.80As of17 May, 00:00 UTC
Profile
CompanyPontex Polyblend Co Ltd
Ticker8935.TWO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Pontex Polyblend Co Ltd designs, develops, and manufactures spare parts and engineering plastics, operating through two segments: Equipment Components and Composite Materials.

Classification. Pontex Polyblend Co Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Pontex Polyblend Co Ltd has a price-to-book ratio of 2.43 and a price-to-tangible-book ratio of 2.43, indicating a premium valuation relative to its book value. The company's market capitalization is 2,099,657,500 TWD, with a market price of 18.5 TWD per share. The enterprise value to EBITDA ratio is negative at -25.61, reflecting the company's current operating losses. The enterprise value to revenue ratio is 4.65, suggesting a moderate revenue-based valuation. The company's profitability is weak, with a return on equity of -0.1 and a return on assets of -0.0596, both significantly below the industry median for Commodity Chemicals. The operating margin is negative at -18.1%, and the net profit margin is also negative at -16.7%, indicating poor cost control and revenue generation relative to its peers. Pontex Polyblend Co Ltd operates through two business segments: Equipment Components and Composite Materials. The geographic exposure is primarily in Taiwan and the rest of Asia, with no specific revenue concentration disclosed. The company's revenue is not heavily concentrated in any single region or customer, but the lack of detailed segment revenue data limits the ability to assess concentration risk. The company's growth trajectory is uncertain, with no specific revenue growth projections provided. The operating cash flow is positive at 13,151,000 TWD, but the free cash flow is negative at -52,559,000 TWD, indicating that the company is not generating sufficient cash to fund its operations and capital expenditures. The capital expenditure for the period is -10,215,000 TWD, suggesting some investment in long-term assets. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company has a debt-to-equity ratio of 0.59 and a current ratio of 1.55, suggesting moderate leverage and adequate short-term liquidity. However, the key flag of negative net cash after subtracting total debt highlights a potential liquidity constraint. Recent events include the publication of the 2023 annual report, which provides the latest financial and operational data. No significant recent filings or transcripts have been disclosed that would indicate major changes in the company's strategic direction or financial health.
Key takeaways
  • Pontex Polyblend Co Ltd is currently unprofitable, with a negative return on equity and return on assets.
  • The company's valuation is premium relative to book value but is challenged by negative operating and net profit margins.
  • The business is diversified across two segments, but geographic and customer concentration data are not disclosed.
  • The company has moderate leverage and adequate short-term liquidity, but its free cash flow is negative.
  • The risk assessment indicates a medium liquidity risk and a low dilution risk.
  • # RATIONALES
  • **margin_outlook_rationale**: The company's operating and net profit margins are negative, indicating poor cost control and revenue generation.
  • **rd_outlook_rationale**: No specific R&D expenditure data is provided to assess the outlook for research and development.
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$518.2M
Gross profit$53.3M
Operating income-$94.1M
Net income-$86.6M
R&D
SG&A
D&A
SBC
Operating cash flow$13.2M
CapEx-$10.2M
Free cash flow-$52.6M
Total assets$1.45B
Total liabilities$587.9M
Total equity$865.8M
Cash & equivalents$199.2M
Long-term debt$509.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$18.50
Market cap$2.10B
Enterprise value$2.41B
P/E
Reported non-GAAP P/E
EV/Revenue4.7
EV/Op income
EV/OCF183.3
P/B2.4
P/Tangible book2.4
Tangible book$865.8M
Net cash-$310.5M
Current ratio1.6
Debt/Equity0.6
ROA-6.0%
ROE-10.0%
Cash conversion-15.0%
CapEx/Revenue-2.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric8935Activity
Op margin-18.2%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-16.7%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin10.3%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity59.0%59.0% medp25 54.9% · p75 72.9%below median
Observations
IR observations
Last actual EPS1.14 TWD
Last actual revenue6,577,950,000 TWD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 04:59 UTC#7aab2745
Market quoteclose TWD 18.50 · shares 0.11B diluted
no public URL
2026-05-10 04:59 UTC#c3b9eeb1
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 05:01 UTCJob: 46de1356